Though Pfizer Inc.’s work on a PD-1-targeting antibody has trailed far behind that of its fellow big pharmas, the company could be the first to market in treatment-naïve, high-risk non-muscle invasive ...

Pfizer's Phase 3 CREST trial results highlight the efficacy of sasanlimab combined with BCG in treating high-risk non-muscle invasive bladder cancer.

Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...

If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...

Pfizer on Friday said the pivotal Phase 3 study evaluating sasanlimab in combination with standard-of-care Bacillus Calmette-Guerin, or BCG, as induction therapy with or without maintenance in ...

Whether you’re a senior in high school or a senior-living resident, you’ve likely heard of Viagra (sildenafil) — the original ...

Science often seems like it's always about careful logic, but really, many discoveries have come about entirely by accident. Here are some of the most notable.

They even generated clinical results that suggested it might have promise as a weight-loss drug as well — only to have Pfizer, which had agreed to fund the research, withdraw its support ...

What we can glean from the pattern of accidental discoveries in science, especially in the pharmaceutical industry, and their broad mental health implications.

“Herbal” or “natural Viagra” is a name given to a variety of supplements by their manufacturers. They’re sold for the purpose of improving erectile function or sexual desire in people ...

The product, marketed as Viagra ODF, offers an accessible alternative ... Interestingly, sildenafil was serendipitously found during an early '90s Pfizer trial for angina relief, revealing ...